Our Blog Melanoma360

Blog - Melanoma360

Featured image for “International Survivor Spotlight:  José Correia, Portugal”
09/24/2021

International Survivor Spotlight: José Correia, Portugal

By Mara Klecker José Correia’s melanoma diagnosis was nearly a quarter-century ago, but he is committed to spreading awareness about…
Blog - Melanoma360
International Advocate Stories
Survivor Stories
Featured image for “Making the Cut For Melanoma: A Mom’s Motivation”
09/24/2021

Making the Cut For Melanoma: A Mom’s Motivation

  By Mara Klecker As a social service director working in long-term care, Traci Cunningham made a promise to her…
Blog - Melanoma360
Friends, Family, & Caregivers
Philanthropy
Featured image for “President’s Letter | September 2021”
09/24/2021

President’s Letter | September 2021

From the Desk of Samantha Guild As I reviewed the articles for this month’s newsletter, I thought about the fact…
Blog - Melanoma360
President's Letter
Featured image for “What is Translational Medicine?”
09/24/2021

What is Translational Medicine?

By Maria Libera Ascierto, MS, PhD Associate Professor Translational Cancer Immunology Director “The Rosalie and Harold R Brown Cancer Immunotherapy”…
Blog - Melanoma360
In Plain English
Featured image for “Melanoma by the State: Oregon”
09/24/2021

Melanoma by the State: Oregon

Let’s start with some fun facts about Oregon: Oregon boasts the deepest lake in the U.S., Crater Lake, with a…
Blog - Melanoma360
Melanoma by the State
Featured image for “Motherhood and Melanoma: Raleigh Minning, Stage III Melanoma Survivor”
09/24/2021

Motherhood and Melanoma: Raleigh Minning, Stage III Melanoma Survivor

By Mara Klecker One of the only times Raleigh Minning cried during her melanoma journey was when she thought of…
Blog - Melanoma360
Survivor Stories
Featured image for “Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma”
09/20/2021

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
09/20/2021

USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

09/20/2021 The application is based on Phase 2/3 RELATIVITY-047 trial, in which the relatlimab and nivolumab fixed-dose combination demonstrated a…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma”
09/18/2021

Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma

LUGANO, Switzerland – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer”
08/25/2021

Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer

August 24, 2021  Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers NEW YORK – Nouscom…
Blog - Melanoma360
Breaking News
Melanoma Research
09/24/2021

International Survivor Spotlight: José Correia, Portugal

By Mara Klecker José Correia’s melanoma diagnosis was nearly a quarter-century ago, but he is committed to spreading awareness about…
Featured image for “International Survivor Spotlight:  José Correia, Portugal”
Blog - Melanoma360
 | 
International Advocate Stories
 | 
Survivor Stories
09/24/2021

Making the Cut For Melanoma: A Mom’s Motivation

  By Mara Klecker As a social service director working in long-term care, Traci Cunningham made a promise to her…
Featured image for “Making the Cut For Melanoma: A Mom’s Motivation”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
09/24/2021

President’s Letter | September 2021

From the Desk of Samantha Guild As I reviewed the articles for this month’s newsletter, I thought about the fact…
Featured image for “President’s Letter | September 2021”
Blog - Melanoma360
 | 
President's Letter
09/24/2021

What is Translational Medicine?

By Maria Libera Ascierto, MS, PhD Associate Professor Translational Cancer Immunology Director “The Rosalie and Harold R Brown Cancer Immunotherapy”…
Featured image for “What is Translational Medicine?”
Blog - Melanoma360
 | 
In Plain English
09/24/2021

Melanoma by the State: Oregon

Let’s start with some fun facts about Oregon: Oregon boasts the deepest lake in the U.S., Crater Lake, with a…
Featured image for “Melanoma by the State: Oregon”
Blog - Melanoma360
 | 
Melanoma by the State
09/24/2021

Motherhood and Melanoma: Raleigh Minning, Stage III Melanoma Survivor

By Mara Klecker One of the only times Raleigh Minning cried during her melanoma journey was when she thought of…
Featured image for “Motherhood and Melanoma: Raleigh Minning, Stage III Melanoma Survivor”
Blog - Melanoma360
 | 
Survivor Stories
09/20/2021

Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage…
Featured image for “Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
09/20/2021

USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

09/20/2021 The application is based on Phase 2/3 RELATIVITY-047 trial, in which the relatlimab and nivolumab fixed-dose combination demonstrated a…
Featured image for “USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
09/18/2021

Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma

LUGANO, Switzerland – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the…
Featured image for “Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
08/25/2021

Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer

August 24, 2021  Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers NEW YORK – Nouscom…
Featured image for “Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research